-
Budget Impact Analysis of Venetoclax Combination Therapies for the Treatment of Newly Diagnosed Acute Myeloid Leukemia Patients Who Are Aged 75 Years or Older, or Who Have Comorbidities That Preclude Use of Intensive Induction Chemotherapy
Mar 10, 2025, 14:00 PM -
Information-Seeking Behavior of the Hungarian Population Regarding Lung Cancer: A Digital Epidemiological Study Using Google Trends™
Mar 10, 2025, 14:00 PM -
Tailoring Generalized Cost-Effectiveness Analysis (GCEA) to the U.S. Setting: the Importance of Using the Right Prices
Mar 10, 2025, 14:00 PM -
Effectiveness of Digital Care Platforms for Cancer Patients: A Systematic Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
The Use of Large Language Models for Systematic Literature Review Automation: An Evaluation of Quality and Time Savings
Mar 10, 2025, 14:00 PM -
Long-Term Cost-Effectiveness of Once-Weekly Insulin Icodec Versus Degludec for the Treatment of Patients With Type 2 Diabetes Mellitus in China
Mar 10, 2025, 14:00 PM -
Population-Level Impact of Emicizumab for Hemophilia A Patients in Six Latin American (LATAM) Countries: A 25-Year Model
Mar 10, 2025, 14:00 PM -
Health-Related Quality of Life and Associated Factors Among Patients With Chronic Diseases in Hainan Province, China
Mar 10, 2025, 14:00 PM -
Real-World Effectiveness of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in Poland in Comparison With Efficacy Reported in Clinical Trials
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Lenvatinib vs Key Comparators in First-Line Unresectable Hepatocellular Carcinoma in Canada
Mar 10, 2025, 14:00 PM -
Budget Impact Model of Enhanced Lung Cancer Screening With AI/ML Tech-Based Software as a Medical Device (SaMD) on a US Cohort and Private Payer Perspective
Mar 10, 2025, 14:00 PM -
Differences in Demographic and Clinical Profiles Among Patients Adherent Vs. Non-Adherent to Revefenacin Following a COPD-Related Hospitalization
Mar 10, 2025, 14:00 PM -
A Real-World Analysis of Patient Cost Burden From COPD and Its Treatment Regimens
Mar 10, 2025, 14:00 PM -
Cost Effectiveness Analysis of Lanadelumab vs C1 Inhibitor for Long-Term Prophylaxis of Hereditary Angioedema: A Brazilian Private Sector Perspective
Mar 10, 2025, 14:00 PM -
Assessing Disease Severity: How HTA Bodiea Evaluate Unmet Needs and Influemce Decision-Making
Mar 10, 2025, 14:00 PM -
Healthcare Resource Use in Commercially- and Medicaid-Insured Infants, Toddlers, and Children Diagnosed With Invasive Meningococcal Disease in the United States
Mar 10, 2025, 14:00 PM -
Early Germline BRCA Testing in Breast Cancer: A Review of Value Frameworks and Cost-Effectiveness Analyses
Mar 10, 2025, 14:00 PM -
Cost-effectiveness of Esketamine versus Real-world Treatments for Patients with Treatment-resistant Depression: A Multi-armed Modelling Study
Mar 10, 2025, 14:00 PM -
Impact of Capacity and Resource Constraints on Wet Age-Related Macular Degeneration and Diabetic Macular Edema in the Brazilian Public Healthcare System: an Individual-Level Microsimulation Study
Mar 10, 2025, 14:00 PM -
Physician-Reported Satisfaction with, Challenges in, and Patient Adherence to, Immunosuppressive Treatment among Kidney Transplant Recipients: Results From a Real-World Survey
Mar 10, 2025, 14:00 PM